Filing Details

Accession Number:
0001209191-19-061776
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-23 16:10:11
Reporting Period:
2019-12-20
Accepted Time:
2019-12-23 16:10:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339469 Chiasma Inc CHMA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647053 Roni Mamluk C/O Chiasma, Inc.
460 Totten Pond Road, Suite 530
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-20 61,139 $0.09 61,139 No 4 M Direct
Common Stock Disposition 2019-12-20 61,139 $5.51 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-12-20 61,139 $0.00 61,139 $0.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-09-20 No 4 M Direct
Footnotes
  1. The sale was effected pursuant to a Rule 10b5-1 trading plan dated May 17, 2019 adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.47 to $5.56, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. This option is fully vested and exercisable.